Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Auto Stem Cell Transplant”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Not applicableLooking for participantsNCT04745221
What this trial is testing

Efficacy and Safety of Auto-FMT in Preventing aGVHD

Who this might be right for
Graft Versus Host Disease, Acute
The First Affiliated Hospital of Soochow University 100
Testing effectiveness (Phase 2)Study completedNCT01402284
What this trial is testing

Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 45
Large-scale testing (Phase 3)Study completedNCT01241708
What this trial is testing

Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaAuto Stem Cell Transplant
Hackensack Meridian Health 148
Testing effectiveness (Phase 2)Study completedNCT07236151
What this trial is testing

Sequential CD19/CD22 CAR-T Cell Therapy Following ASCT

Who this might be right for
Large B-cell LymphomaCAR T Cell TherapyAuto Stem Cell Transplant
The First Affiliated Hospital of Soochow University 23
Large-scale testing (Phase 3)Study completedNCT00114530
What this trial is testing

Scleroderma: Cyclophosphamide or Transplantation

Who this might be right for
Scleroderma, SystemicSclerosisAutoimmune Disease
National Institute of Allergy and Infectious Diseases (NIAID) 75
Testing effectiveness (Phase 2)Study completedNCT02141451
What this trial is testing

ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL

Who this might be right for
Diffuse Large B Cell Non-Hodgkin Lymphoma
Masonic Cancer Center, University of Minnesota 30
Large-scale testing (Phase 3)Study completedNCT00129090
What this trial is testing

Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)
German High-Grade Non-Hodgkin's Lymphoma Study Group 450
Testing effectiveness (Phase 2)Active Not RecruitingNCT05493800
What this trial is testing

Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT

Who this might be right for
Oral MucositisLymphomaMultiple Myeloma+1 more
MitoImmune Therapeutics 60
Large-scale testing (Phase 3)UnknownNCT03695055
What this trial is testing

Maintenance Therapy Post-HSCT in High-risk Aggressive Lymphoma

Who this might be right for
High-risk Aggressive Lymphoma After Auto-HSCT
Fujian Medical University 60
Testing effectiveness (Phase 2)Study completedNCT04682405
What this trial is testing

Uproleselan (GMI-1271) for GI Toxicity Prophylaxis During Melphalan-Conditioned Autologous Hematopoietic Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 51
Not applicableStudy completedNCT02439476
What this trial is testing

Non-interventional Study on Salvage Auto in Relapsed Myeloma

Who this might be right for
Relapsed Multiple Myeloma
Association for Training, Education, and Research in Hematology, Immunology, and Transplantation 23
Large-scale testing (Phase 3)Study completedNCT02671708
What this trial is testing

IDA+BUCY vs BUCY Conditioning Regimen for Intermediate-risk AML Undergoing Auto-HSCT

Who this might be right for
Autologous Hematopoietic Stem Cell TransplantationAcute Myeloid LeukemiaConditioning
Nanfang Hospital, Southern Medical University 153
Early research (Phase 1)Study completedNCT02655458
What this trial is testing

Elotuzumab in Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hearn Jay Cho 15
Large-scale testing (Phase 3)Active Not RecruitingNCT03948035
What this trial is testing

Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM

Who this might be right for
Newly Diagnosed Multiple Myeloma
Wuerzburg University Hospital 576
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07070934
What this trial is testing

CAR-T vs. Auto-SCT: Which Works Better for New Myeloma Patients?

Who this might be right for
Multiple MyelomaNewly Diagnosed
Xuzhou Medical University 60
Testing effectiveness (Phase 2)UnknownNCT00702247
What this trial is testing

Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi)

Who this might be right for
Multiple Myeloma
Azienda Ospedaliera San Giovanni Battista
Post-approval studies (Phase 4)UnknownNCT03707847
What this trial is testing

Crizotinib Combined With Etoposide Capsule Followed by Auto-HSCT for Relapsed and Refractory ALK+ ALCL

Who this might be right for
ALK-Positive Anaplastic Large Cell Lymphoma
Mingzhi Zhang 20
Early research (Phase 1)Study completedNCT03383055
What this trial is testing

CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig

Who this might be right for
LymphomaMultiple Myeloma
Masonic Cancer Center, University of Minnesota 28
Testing effectiveness (Phase 2)Looking for participantsNCT06608342
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia ALL
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableLooking for participantsNCT07253129
What this trial is testing

Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)

Who this might be right for
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 88
Load More Results